Biotech
48 total deals across 43 companies.
Latest Funding
Company
Location
Latest Round
Amount
Date

Aardaia
Wageningen, Netherlands
—
Seed
$5.8M
Jul 8, 2026

Epitome Therapeutics
Vienna, Austria
—
Pre-Seed
$4.6M
Jun 30, 2026

Intu Diagnostics
Leipzig, Germany
—
Funding
$1.3M
Jun 26, 2026

Thalia Therapeutics
United Kingdom
—
Funding
$3.6M
Jun 26, 2026

Leyden Labs
Leiden, Netherlands
—
Funding
$45.2M
Jun 25, 2026

ChemT Biotechnology
Singapore, Singapore
—
Seed
$4.0M
Jun 22, 2026

Houdini Bio
Cambridge, United Kingdom
—
Pre-Seed
$2.0M
Jun 22, 2026

Vivici
Netherlands
—
Eic Accelerator
$14.5M
Jun 18, 2026

Zumutor Biologics
Bengaluru, India
—
Pre-Series B
$7.3M
Jun 15, 2026

Fesarius Therapeutics
Brooklyn, United States
—
Series A
$20.0M
Jun 10, 2026

Nanordica Medical
Tallinn, Estonia
—
Funding
$1.8M
Jun 10, 2026

Immuneel Therapeutics
Bengaluru, India
—
Series B
$10.5M
Jun 8, 2026

New Dawn Bio
Wageningen, Netherlands
—
Pre-Seed
$2.4M
Jun 4, 2026

IMU Biosciences
London, United Kingdom
—
Series A
$53.0M
Jun 2, 2026

hephaistos.bio
Zurich, Switzerland
—
Funding
$182K
Jun 1, 2026

AlleSense
Melbourne, Australia
—
Funding
$3.3M
May 28, 2026

Perceptic
London, United Kingdom
—
Seed
$12.0M
May 28, 2026

Pacifico Biolabs
Berlin, Germany
—
Series A
$7.9M
May 27, 2026

iFAST Diagnostics
Oxford, United Kingdom
—
Funding
$6.3M
May 27, 2026

Phytolon
Yokneam Illit, Israel
—
Series B
$23.6M
May 26, 2026

StrainX Bioworks
Bhopal, India
—
Funding
$13.0M
May 25, 2026

Efferon
Villach, Austria
—
Seed
$2.9M
May 21, 2026

Imperagen
Manchester, United Kingdom
—
Seed
$6.8M
May 21, 2026

QuberTech
Harpenden, United Kingdom
—
Funding
$4.6M
May 20, 2026

Cellogen Therapeutics
Noida, India
—
Funding
$2.0M
May 19, 2026

Alcolase
Copenhagen, Denmark
—
Seed
$1.7M
May 18, 2026

Melazyme
Singapore
—
Seed
$2.0M
May 14, 2026

Resurrect Bio
United Kingdom
—
Series A
$8.8M
May 14, 2026

Isomorphic Labs
London, United Kingdom
—
Series B
$2.1B
May 12, 2026

Tolemy Bio
Cambridge, United Kingdom
—
Pre-Seed
$1.5M
May 12, 2026

Algorithmiq
Milan, Italy
—
Series B
$21.0M
May 11, 2026

Cellply
Bologna, Italy
—
Growth
$8.3M
May 11, 2026

NanoStruct
Würzburg, Germany
—
Seed
$3.0M
May 11, 2026

Meatly
London, United Kingdom
—
Series A
$12.9M
May 7, 2026

Cytospire Therapeutics
London, United Kingdom
—
Series A
$61.0M
May 6, 2026

EnteroBiotix
Bellshill, United Kingdom
—
Growth
$25.0M
May 4, 2026

Moleculent
Solna, Sweden
—
Growth
$20.0M
May 4, 2026

BioOrbit
United Kingdom
—
Seed
$13.2M
Apr 30, 2026

STORM Therapeutics
Cambridge, United Kingdom
—
Series C
$51.5M
Apr 16, 2026

Generare
Paris, France
—
Series A
$21.6M
Apr 2, 2026

Semarion
Cambridge, United Kingdom
—
Seed
$3.8M
Mar 31, 2026

Parabilis Medicines
Cambridge, United States
—
Series F
$305.0M
Jan 8, 2026

CrisprBits
Bangalore, India
—
Pre-Series A
$3.0M
Nov 1, 2025